Business
Investor Presentation covering Full Year Results
Investor Presentation covering Full Year Results.
About this update from Eco Animal Health Group Plc
[{"type":"text","content":"\n\n12 July 2024\n \n \nECO Animal Health Group plc\n(''ECO\" or the \"Company\")\n \nInvestor Presentation covering Full Year Results\n\nECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, is pleased to announce that David Hallas, CEO, and Christopher Wilks, CFO, will be conducting a live presentation covering the Group's Full Year results for the period ended 31 March 2024.\nThe online presentation will take place on Tuesday 16 July at 16:00 BST. This event is open to all existing and potential shareholders and registration is free. Questions can be submitted during the presentation and will be addressed at the end of it.\nTo register for the event, please click here. \nA video recording of the presentation will be available shortly afterwards here.\n \nContacts:\n \n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n\n\n020 3709 5700\[email protected]\n \n\n\n\n\nAbout ECO Animal Health\n \nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\n \nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.\n \nOur lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. \n \nClick here for more information: https://ecoanimalhealth.com\n \n \n\n","length":6023,"tagName":"div"}]